Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
| Index | ECPI Global ESG Medical Tech |
| Investment focus | Equity, World, Health Care, Social/Environmental |
| Fund size | EUR 2 m |
| Total expense ratio | 0.31% p.a. |
| Replication | Physical (Full replication) |
| Legal structure | ETF |
| Strategy risk | Long-only |
| Sustainability | Yes |
| Fund currency | EUR |
| Currency risk | Currency unhedged |
| Volatility 1 year (in EUR) | 13.52% |
| Inception/ Listing Date | 10 December 2021 |
| Distribution policy | Accumulating |
| Distribution frequency | - |
| Fund domicile | Luxembourg |
| Fund Provider | BNP Paribas Easy |
| Fund Structure | Company With Variable Capital (SICAV) |
| UCITS compliance | Yes |
| Administrator | BNP PARIBAS SECURITIES SERVICES-LUXEMBOURG BRANCH |
| Investment Advisor | |
| Custodian Bank | BNP PARIBAS, Luxembourg Branch |
| Revision Company | PricewaterhouseCoopers Société Coopérative |
| Fiscal Year End | 20 May |
| Swiss representative | BNP Paribas, Paris, Zurich Branch. |
| Swiss paying agent | BNP PARIBAS, Paris, Zurich Branch |
| Germany | 30% tax rebate |
| Switzerland | ESTV Reporting |
| Austria | Tax Reporting Fund |
| UK | No UK Reporting |
| Indextype | Total return index |
| Swap counterparty | - |
| Collateral manager | |
| Securities lending | No |
| Securities lending counterparty |
| argenx | 2.71% |
| Alnylam Pharmaceuticals | 2.71% |
| IQVIA Holdings | 2.57% |
| Genmab A/S | 2.52% |
| Thermo Fisher Scientific | 2.48% |
| EssilorLuxottica SA | 2.46% |
| HOYA Corp. | 2.42% |
| BeOne Medicines Ltd. | 2.33% |
| Smith & Nephew plc | 2.27% |
| Agilent Technologies | 2.27% |
| Health Care | 91.65% |
| Consumer Discretionary | 2.46% |
| Other | 5.89% |
| YTD | +0.69% |
| 1 month | +2.58% |
| 3 months | +3.55% |
| 6 months | +8.17% |
| 1 year | -2.78% |
| 3 years | +1.27% |
| 5 years | - |
| Since inception (MAX) | -12.60% |
| 2024 | +3.21% |
| 2023 | +1.69% |
| 2022 | -17.87% |
| 2021 | - |
| Volatility 1 year | 13.52% |
| Volatility 3 years | 12.51% |
| Volatility 5 years | - |
| Return per risk 1 year | -0.21 |
| Return per risk 3 years | 0.03 |
| Return per risk 5 years | - |
| Maximum drawdown 1 year | -19.57% |
| Maximum drawdown 3 years | -19.57% |
| Maximum drawdown 5 years | - |
| Maximum drawdown since inception | -26.34% |
| Listing | Trade Currency | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
|---|---|---|---|---|---|
| gettex | EUR | ASRP | - - | - - | - |
| Borsa Italiana | EUR | EGEMT | MEDTE IM IMEDT | MEDTE.MI MEDTEINAV=IHSM | BNP aribas Arbitrage |
| Euronext Paris | EUR | MEDTE | MEDTE FP IMEDT | MEDTE.PA MEDTEINAV=IHSM | BNP aribas Arbitrage |
| SIX Swiss Exchange | EUR | MEDTE | MEDTE SW IMEDT | MEDTE.S MEDTEINAV=IHSM | BNP aribas Arbitrage |
| XETRA | EUR | ASRP | ASRP GY IMEDT | ASRP.DE MEDTEINAV=IHSM | BNP aribas Arbitrage |
| Fund name | Fund Size in m € (AuM) | TER p.a. | Distribution | Replication |
|---|---|---|---|---|
| iShares MSCI World Health Care Sector Advanced UCITS ETF USD (Dist) | 438 | 0.18% p.a. | Distributing | Full replication |